Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis
Key Data:
Drug (brand / generic)
Licofelone (ML3000)
Company / licensee
Merckle GmbH and EuroAlliance partners Alfa Wassermann and Lacer
Therapy class
Dual COX/LOX inhibitor
Product description
Inhibits the action of COX and 5-LOX enzymes
Current indication
Treatment of pain and inflammation associated with OA
Market sector
CNS - pain
Development status
Phase III
